There has been a substantial progress in the understanding of cellular events that links the activation of GPCR and ERK (for review, see (1)). These signaling events can be classified into several distinct pathways. They include (i) Ras-dependent activation of ERK via transactivation of receptor tyrosine kinases (RTKs) such as EGFR; (ii) Ras-independent ERK activation via protein kinase C (PKC) that converges with the RTK signaling at the Raf level; (iii) activation or inhibition of ERK via the cAMP/protein kinase A (PKA) pathway, in which the direction of regulation depends on the type of Raf involved; (iv) recently substantiated -arrestin-mediated pathway proven in certain classes of GPCRs (3). However, it should be mentioned that these signaling pathways are deduced from the limited sets of individual receptors or cell types, and more extensive and systemic studies are needed for these signaling models to be generalized (4).
membranes were incubated for 1 hr at room temperature in TBS-T containing 5% nonfat dry milk or 4% BSA, followed by 1 hr incubation with antibodies to phospho-ERK (1:1,000 dilution) and 1 hr with alkaline phosphatase conjugated secondary antibodies (1:5,000) in 2% nonfat dry milk. Blots were visualized with chemiluminescent western blotting kit. The same samples were processed as in phospho-ERK detection except that the membranes were probed with antibodies for ERK.
Immunocytochemistry. The same experimental procedures were used as previously reported [Tohgo, 2002 #141] . For the co-localization studies between -arrestin and phospho-ERK, HEK-293 cells transiently expressing D 2 R or D 3 R and -arrestin 2-GFP were grown in collagen-coated 35-mm glass bottom dishes (confocal dishes). Following dopamine stimulation for 5 min, cells were fixed with 4% paraformaldehyde for 20 min at room temperature, permeabilized with absolute methanol for 10 min at 20 °C, and blocked with PBS containing 1% BSA, 5% FBS for 2 hr at room temperature. Immunofluorescent labeling of endogenous phospho-ERK1/2 was done with a 1:500 dilution of rabbit polyclonal antiphospho-ERK1/2 antibody in PBS containing 1% BSA, 1% FBS for 18 hr at room temperature, followed by a 1:500 dilution Texas Red®-conjugated polyclonal anti-rabbit IgG antibody in 1% BSA, 1% FBS for 1 hr at room temperature. Confocal microscopy was performed using a Zeiss LSM510 laser scanning microscope dual line switching excitation (488 nm for GFP and 568 nm for Texas Red®) and emission (515-540 nm for GFP and 590-620 nm for Texas Red®) filter sets.
RESULTS

Characterization of D 2 R-and D 3 R-mediated Activation of ERK1/2 in HEK-293 cells.
The time course and dose response relationship of D 2 R-and D 3 R-mediated ERK activation, were studied in HEK-293 cells, which were transiently transfected with cDNAs encoding D 2 R or D 3 R (since D 2S R was mainly used in this study, D 2 R refers to D 2S R unless specified). As shown in Fig.1 , the phosphorylation of p44 and p42 forms of ERK (ERK1/2) was transient (Fig.1C) . 
Involvement of PTX-sensitive G protein in the D 2 R-and D 3 R-mediated
Receptor Sequestration Is Not a Requirement for the ERK Activation by D 2 R and D 3 R.
Recently, it has been suggested for certain GPCRs that receptor internalization may be required for the activation of the ERK cascades in certain occasions (26,27). On the other hand, receptor sequestration is not necessary for ERK activation of some GPCRs (28). We wanted to test whether receptor internalization is required for the D 2 R-and D 3 R-mediated ERK activation. We examined the relationship between receptor internalization and ERK activation by blocking the receptor internalization using dynamin dominant negative mutant K44A and sucrose. In addition, we modulated the receptor sequestration by co-expressing GRK/ -arrestins, and tested their effects on ERK activation. There have been studies that showed the regulation of inositol phosphate production by D2-like receptors (32,33), and we tested whether PLC activation was required for D 2 Rand D 3 R-mediated ERK phosphorylation using the pharmacological PLC inhibitor, U-73122.
As shown in However, it is not clear whether the new role of -arrestin can be extended for other GPCRs.
In this study, we tested the involvement of -arrestins for D 2 R-and D 3 R-mediated ERK activation by co-expressing -arrestins or dominant negative -arrestin I V53D mutant. We also tested whether agonist-activated phospho-ERK (pERK) and translocated -arrestin colocalize at the same subcellular regions as reported in AT 1A R.
DISCUSSION
ERK activation cascade is relatively well understood in receptor tyrosine kinases. For example, EGFR is phosphorylated on tyrosine residues by EGF stimulation, and phosphorylated EGFR binds to its adaptor proteins, such as Grb2, and then to SOS that has a stimulatory effect on the GDP/GTP exchange of Ras (48) (49) . EGFR-adaptor complex activates Raf and MEK, which is followed by phosphorylation of ERK. ERK then translocates to the nucleus, where it phosphorylates a number of transcription factors, which ultimately regulate the gene expression essential for cell proliferation (50) . Since the subunit of G i proteins are known to transactivate EGFR, the detailed signaling pathway of EGFR described above might be considered as subunit pathway of G i protein (51) Immunoblotting was conducted as described in Fig.1 
